Amgen’s Bundling Of ESAs With Neulasta and Neupogen Draws House Scrutiny

Amgen's offering of discounts to physicians and clinics for purchasing the white blood cell growth factors Neulasta and Neupogen together with the erythropoiesis-stimulation agents Aranesp (darbepoetin alfa) and Epogen (epoetin alfa) has once again come under scrutiny, this time from the House Energy and Commerce Committee